Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study
Background: Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its use in PE treatment is needed. Objectives: This study was aimed at evaluating the safety a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2025-01-01
|
| Series: | Cardiovascular Innovations and Applications |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0066 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825201946528579584 |
|---|---|
| author | Wenguang Zhang Tao Hu Song Ding Zhouming Wang Tao Zhang Hongyao Hu Xin Fang Honggang Pang Mingjin Guo Bo Yu Hui Zhuang Nuofu Zhang Baoshi Han Qiguang Wang Mingzhi Cai Kuan Wang Pingfan Guo Bin Xu Peiliang Fang Shengxian Tu Yi Jiang Hongyu Shi Zhenwen Yang Xinwei Han Hongyan Tian Jun Pu Xiaoming Zhang |
| author_facet | Wenguang Zhang Tao Hu Song Ding Zhouming Wang Tao Zhang Hongyao Hu Xin Fang Honggang Pang Mingjin Guo Bo Yu Hui Zhuang Nuofu Zhang Baoshi Han Qiguang Wang Mingzhi Cai Kuan Wang Pingfan Guo Bin Xu Peiliang Fang Shengxian Tu Yi Jiang Hongyu Shi Zhenwen Yang Xinwei Han Hongyan Tian Jun Pu Xiaoming Zhang |
| author_sort | Wenguang Zhang |
| collection | DOAJ |
| description | Background: Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its use in PE treatment is needed. Objectives: This study was aimed at evaluating the safety and efficacy of the Tendvia system for intermediate-risk acute PE. Methods: This prospective, single-arm, multicenter study included symptomatic patients with acute PE ≥18 years of age, with a right ventricular (RV)/left ventricular (LV) diameter ratio ≥0.9. The primary efficacy endpoint was the change in RV/LV diameter ratio from baseline to 48 hours postprocedure. The primary safety endpoint was the incidence of major adverse events (AEs), device-related death, 48-hour postprocedure major bleeding, pulmonary vascular injury, and cardiac injury. The secondary efficacy endpoint was the systolic pulmonary arterial pressure (PAP) change from pre- to postprocedure. Secondary safety endpoints included 48-hour postprocedure clinical deterioration, device-related AEs, and symptomatic PE recurrence within 30 days. Results: Of 127 patients at 15 centers with intermediate-risk acute PE who underwent mechanical thrombectomy with the Tendvia system (September 2021 to December 2022), 123 underwent analysis. The mean RV/LV diameter ratio decrease was 0.42 ± 0.28; 95% CI: 0.37–0.47; P < 0.001. The bleeding risk was low, and the hospitalization duration was short. One patient experienced clinical deterioration within 48 hours, and none experienced major AEs, device-related pulmonary vascular injury, cardiac injury, or major bleeding within 48 hours. Seven patients had 11 serious AEs within 30 days. The mean systolic PAP decrease was 7.10 mmHg (P < 0.001). Conclusion: The Tendvia system for mechanical thrombectomy is safe and effective for intermediate-risk acute PE, in agreement with the safety profiles in other studies. |
| format | Article |
| id | doaj-art-cd2e0272d3c64aba8108c8ac75f71a5b |
| institution | Kabale University |
| issn | 2009-8618 2009-8782 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Compuscript Ltd |
| record_format | Article |
| series | Cardiovascular Innovations and Applications |
| spelling | doaj-art-cd2e0272d3c64aba8108c8ac75f71a5b2025-02-07T17:00:11ZengCompuscript LtdCardiovascular Innovations and Applications2009-86182009-87822025-01-0110198810.15212/CVIA.2024.0066Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR StudyWenguang ZhangTao HuSong DingZhouming WangTao ZhangHongyao HuXin FangHonggang PangMingjin GuoBo YuHui ZhuangNuofu ZhangBaoshi HanQiguang WangMingzhi CaiKuan WangPingfan GuoBin XuPeiliang FangShengxian TuYi JiangHongyu ShiZhenwen YangXinwei HanHongyan TianJun PuXiaoming ZhangBackground: Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its use in PE treatment is needed. Objectives: This study was aimed at evaluating the safety and efficacy of the Tendvia system for intermediate-risk acute PE. Methods: This prospective, single-arm, multicenter study included symptomatic patients with acute PE ≥18 years of age, with a right ventricular (RV)/left ventricular (LV) diameter ratio ≥0.9. The primary efficacy endpoint was the change in RV/LV diameter ratio from baseline to 48 hours postprocedure. The primary safety endpoint was the incidence of major adverse events (AEs), device-related death, 48-hour postprocedure major bleeding, pulmonary vascular injury, and cardiac injury. The secondary efficacy endpoint was the systolic pulmonary arterial pressure (PAP) change from pre- to postprocedure. Secondary safety endpoints included 48-hour postprocedure clinical deterioration, device-related AEs, and symptomatic PE recurrence within 30 days. Results: Of 127 patients at 15 centers with intermediate-risk acute PE who underwent mechanical thrombectomy with the Tendvia system (September 2021 to December 2022), 123 underwent analysis. The mean RV/LV diameter ratio decrease was 0.42 ± 0.28; 95% CI: 0.37–0.47; P < 0.001. The bleeding risk was low, and the hospitalization duration was short. One patient experienced clinical deterioration within 48 hours, and none experienced major AEs, device-related pulmonary vascular injury, cardiac injury, or major bleeding within 48 hours. Seven patients had 11 serious AEs within 30 days. The mean systolic PAP decrease was 7.10 mmHg (P < 0.001). Conclusion: The Tendvia system for mechanical thrombectomy is safe and effective for intermediate-risk acute PE, in agreement with the safety profiles in other studies.https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0066 |
| spellingShingle | Wenguang Zhang Tao Hu Song Ding Zhouming Wang Tao Zhang Hongyao Hu Xin Fang Honggang Pang Mingjin Guo Bo Yu Hui Zhuang Nuofu Zhang Baoshi Han Qiguang Wang Mingzhi Cai Kuan Wang Pingfan Guo Bin Xu Peiliang Fang Shengxian Tu Yi Jiang Hongyu Shi Zhenwen Yang Xinwei Han Hongyan Tian Jun Pu Xiaoming Zhang Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study Cardiovascular Innovations and Applications |
| title | Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study |
| title_full | Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study |
| title_fullStr | Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study |
| title_full_unstemmed | Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study |
| title_short | Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study |
| title_sort | mechanical thrombectomy system for the treatment of intermediate risk acute pulmonary embolism the clear study |
| url | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0066 |
| work_keys_str_mv | AT wenguangzhang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT taohu mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT songding mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT zhoumingwang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT taozhang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT hongyaohu mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT xinfang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT honggangpang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT mingjinguo mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT boyu mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT huizhuang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT nuofuzhang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT baoshihan mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT qiguangwang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT mingzhicai mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT kuanwang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT pingfanguo mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT binxu mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT peiliangfang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT shengxiantu mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT yijiang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT hongyushi mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT zhenwenyang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT xinweihan mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT hongyantian mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT junpu mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy AT xiaomingzhang mechanicalthrombectomysystemforthetreatmentofintermediateriskacutepulmonaryembolismtheclearstudy |